Oxaliplatin-induced haematological emergency with an immediate severe thrombocytopenia and haemolysis.
Sørbye
H
H
Department of Oncology, Haukeland University Hospital, Bergen, Norway. half@haukeland.no
Bruserud
Y
Y
Dahl
O
O
D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001803:Blood Transfusion; D003110:Colonic Neoplasms / Q000188:drug therapy; D005472:Fluorouracil / Q000008:administration & dosage; D006461:Hemolysis / Q000187:drug effects*; D006801:Humans; D007074:Immunoglobulin G / Q000032:analysis; D002955:Leucovorin / Q000008:administration & dosage; D008297:Male; D008875:Middle Aged; D009944:Organoplatinum Compounds / Q000008:administration & dosage / Q000009:adverse effects*; D000077150:Oxaliplatin; D013921:Thrombocytopenia / Q000139:chemically induced*
D000970:Antineoplastic Agents; D007074:Immunoglobulin G; D009944:Organoplatinum Compounds; D000077150:Oxaliplatin; D002955:Leucovorin; D005472:Fluorouracil